EL.En. S.p.A. (BIT:ELN)
Italy · Delayed Price · Currency is EUR 15.58
-0.04 (-0.26%)
Aug 17, 2026, 1:12 PM CET
EL.En. Revenue
EL.En. had revenue of 149.35M EUR in the quarter ending March 31, 2026, with 7.27% growth. This brings the company's revenue in the last twelve months to 748.26M, up 172.54% year-over-year. In the year 2025, EL.En. had annual revenue of 596.91M with 4.23% growth.
Revenue (ttm)
748.26M
Revenue Growth
+172.54%
P/S Ratio
2.10
Revenue / Employee
431.84K
Employees
1,428
Market Cap
1.25B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 596.91M | 24.23M | 4.23% |
| Dec 31, 2024 | 572.68M | -8.13M | -1.40% |
| Dec 31, 2023 | 580.80M | -99.00M | -14.56% |
| Dec 31, 2022 | 679.81M | 102.42M | 17.74% |
| Dec 31, 2021 | 577.39M | 163.57M | 39.53% |
| Dec 31, 2020 | 413.82M | 9.58M | 2.37% |
| Dec 31, 2019 | 404.23M | 52.60M | 14.96% |
| Dec 31, 2018 | 351.63M | 40.91M | 13.17% |
| Dec 31, 2017 | 310.73M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 2.71B |
| Amplifon | 2.40B |
| DiaSorin | 1.18B |
| Safilo Group | 957.72M |
| GPI S.p.A. | 546.18M |
| Garofalo Health Care | 489.26M |
| Philogen | 319.73M |
| Svas Biosana | 141.56M |
EL.En. News
- 3 months ago - EL.En. Earnings Call Transcript: Q1 2026 - Transcripts
- 3 months ago - EL.En. Earnings release: Q1 2026 - Filings
- 3 months ago - EL.En. Slides: Q1 2026 - Filings
- 3 months ago - EL.En. Quarterly report: Q1 2026 - Filings
- 5 months ago - EL.En. Slides: Investor presentation - Filings
- 5 months ago - EL.En. Earnings Call Transcript: Q4 2025 - Transcripts
- 5 months ago - EL.En. Earnings release: Q4 2025 - Filings
- 5 months ago - EL.En. Slides: Q4 2025 - Filings